Lundbeck is conducting a Pregnancy Registry for women diagnosed with migraine who have been treated with certain preventive migraine medications during pregnancy or up to 20 weeks (depending on medication) prior to becoming pregnant.
This pregnancy registry is a research study that collects information about the possible effects of certain migraine medications on pregnant women, and their developing fetuses through the first year of the baby’s life. You’ll be asked to record your medication use in a diary throughout the pregnancy and have periodic check-ins through the first year of the baby’s life. By participating, you can help improve the future of migraine preventive treatments for pregnant women.
Learn more & see if you qualify. You can also talk to your doctor to see if this study is relevant for you.
The VYEPTI Pregnancy Registry is intended for research purposes only.